Literature DB >> 31553322

Health systems for rare diseases: financial sustainability.

Georgi Iskrov1, Rumen Stefanov1, Rita Maria Ferrelli2.   

Abstract

INTRODUCTION: Distribution of public spending on health depends on a variety of factors, from disease burden and system priorities to organisational aspects and costs. Nowadays, virtually all health care systems face serious sustainability challenges. This is particularly true for rare diseases, where priority setting involves complex and often controversial value-laden choices.
METHOD: The theoretical framework underlying the approach of this work is based upon the State of Health in the EU, a two-year initiative undertaken by the European Commission and developed in cooperation with the Organisation for Economic Co-operation and Development and the European Observatory on Health Systems and Policies.
RESULTS: The 2017 report identified five cross-cutting sustainability issues: health promotion and disease prevention, primary care, integrated care, health workforce planning and forecasting, person-centred health data.Implications and recommendations. Rare diseases have been one of the priorities of the Community's programmes for research and development. The EU has stimulated a series of actions in the field of rare diseases. These project activities could set up the practical cooperation and come up with the knowledge to translate and to work on the identified five key challenges of EU Member States health systems' sustainability and resilience.

Entities:  

Mesh:

Year:  2019        PMID: 31553322     DOI: 10.4415/ANN_19_03_13

Source DB:  PubMed          Journal:  Ann Ist Super Sanita        ISSN: 0021-2571            Impact factor:   1.663


  3 in total

Review 1.  How can the healthcare system deliver sustainable performance? A scoping review.

Authors:  Yvonne Zurynski; Jessica Herkes-Deane; Joanna Holt; Elise McPherson; Gina Lamprell; Genevieve Dammery; Isabelle Meulenbroeks; Nicole Halim; Jeffrey Braithwaite
Journal:  BMJ Open       Date:  2022-05-24       Impact factor: 3.006

2.  Educational and knowledge gaps within the European reference network on rare endocrine conditions.

Authors:  Violeta Iotova; Camilla Schalin-Jäntti; Petra Bruegmann; Manuela Broesamle; Natasa Bratina; Vallo Tillmann; Olaf Hiort; Alberto M Pereira
Journal:  Endocr Connect       Date:  2021-01       Impact factor: 3.335

Review 3.  Establishing a second-generation artificial intelligence-based system for improving diagnosis, treatment, and monitoring of patients with rare diseases.

Authors:  Noa Hurvitz; Henny Azmanov; Asa Kesler; Yaron Ilan
Journal:  Eur J Hum Genet       Date:  2021-07-19       Impact factor: 5.351

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.